4.6 Article

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease

Journal

PLOS ONE
Volume 10, Issue 4, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0122731

Keywords

-

Funding

  1. TUM Graduate School of Information Science in Health (GSISH), Technische Universitat Munchen
  2. Johannes Gutenberg-Universitat Mainz

Ask authors/readers for more resources

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term pattern stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called region of interest (ROI). In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the characteristics of the given data, given some prior anatomical knowledge. A Gaussian Mixture Model (GMM) and model selection are combined to return a clustering of voxels that may serve for the definition of ROIs. Experiments on both an in-house dataset and data of the Alzheimer's Disease Neuroimaging Initiative (ADNI) suggest that the proposed approach arrives at a better diagnosis than a merely anatomical approach or conventional statistical hypothesis testing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Clinical

Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction

Franziska Maier, Andrea Greuel, Marius Hoock, Rajbir Kaur, Masoud Tahmasian, Frank Schwartz, Ilona Csoti, Frank Jessen, Alexander Drzezga, Thilo van Eimeren, Lars Timmermann, Carsten Eggers

Summary: This study investigated impaired self-awareness of cognitive deficits in Parkinson's disease (PD) and its associations with clinical-behavioral and neuroimaging markers. The results showed that PD patients with mild cognitive impairment (PD-MCI) had significantly higher impaired self-awareness than healthy controls and PD patients without MCI. Neuroimaging analysis revealed that glucose metabolism in the cingulate cortex was negatively correlated with impaired self-awareness. In PD-MCI patients, impaired self-awareness was associated with decreased metabolism in the right temporal lobe, insula, and midcingulate cortex. These findings suggest that impaired self-awareness of cognitive deficits in PD may be related to disruptions in the cognitive network and metabolic changes in specific brain regions.

PSYCHOLOGICAL MEDICINE (2023)

Article Clinical Neurology

Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort

Zachary Winder, Tiffany L. Sudduth, Sonya Anderson, Ela Patel, Janna Neltner, Barbara J. Martin, Katherine E. Snyder, Erin L. Abner, Gregory A. Jicha, Peter T. Nelson, Donna M. Wilcock

Summary: The study evaluated the relationship between plasma biomarkers and neuropathology associated with Alzheimer's disease (AD) and vascular contributions to cognitive impairment and dementia (VCID). The results showed certain plasma biomarkers were associated with AD and VCID pathology, providing support for further research in using plasma biomarkers as a clinical screening tool.

ALZHEIMERS & DEMENTIA (2023)

Article Biochemistry & Molecular Biology

Impact of pre-analytical sample handling factors on plasma biomarkers of Alzheimer's disease

Carolin Kurz, Laura Stoeckl, Isabelle Schrurs, Ivonne Suridjan, Selim Uestuen Guersel, Tobias Bittner, Alexander Jethwa, Robert Perneczky

Summary: An investigation was conducted on the impact of different pre-analytical sample handling procedures on plasma biomarkers for Alzheimer's disease (AD). The effects of storage time, freeze/thaw cycles, anticoagulants, tube transfer, and tube types were evaluated. The results provide recommendations for an optimal sample handling protocol to improve the reproducibility of future studies on plasma biomarkers assays for AD.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium

Constantinos Constantinides, Laura K. M. Han, Clara Alloza, Linda Antonella Antonucci, Celso Arango, Rosa Ayesa-Arriola, Nerisa Banaj, Alessandro Bertolino, Stefan Borgwardt, Jason Bruggemann, Juan Bustillo, Oleg Bykhovski, Vince Calhoun, Vaughan Carr, Stanley Catts, Young-Chul Chung, Benedicto Crespo-Facorro, Covadonga M. Diaz-Caneja, Gary Donohoe, Stefan Du Plessis, Jesse Edmond, Stefan Ehrlich, Robin Emsley, Lisa T. Eyler, Paola Fuentes-Claramonte, Foivos Georgiadis, Melissa Green, Amalia Guerrero-Pedraza, Minji Ha, Tim Hahn, Frans A. Henskens, Laurena Holleran, Stephanie Homan, Philipp Homan, Neda Jahanshad, Joost Janssen, Ellen Ji, Stefan Kaiser, Vasily Kaleda, Minah Kim, Woo-Sung Kim, Matthias Kirschner, Peter Kochunov, Yoo Bin Kwak, Jun Soo Kwon, Irina Lebedeva, Jingyu Liu, Patricia Mitchie, Stijn Michielse, David Mothersill, Bryan Mowry, Victor Ortiz-Garcia de la Foz, Christos Pantelis, Giulio Pergola, Fabrizio Piras, Edith Pomarol-Clotet, Adrian Preda, Yann Quide, Paul E. Rasser, Kelly Rootes-Murdy, Raymond Salvador, Marina Sangiuliano, Salvador Sarro, Ulrich Schall, Andre Schmidt, Rodney J. Scott, Pierluigi Selvaggi, Kang Sim, Antonin Skoch, Gianfranco Spalletta, Filip Spaniel, Sophia Thomopoulos, David Tomecek, Alexander S. Tomyshev, Diana Tordesillas-Gutierrez, Therese van Amelsvoort, Javier Vazquez-Bourgon, Daniela Vecchio, Aristotle Voineskos, Cynthia S. Weickert, Thomas Weickert, Paul M. Thompson, Lianne Schmaal, Theo G. M. van Erp, Jessica Turner, James H. Cole, Danai Dima, Esther Walton

Summary: Schizophrenia patients show evidence of advanced brain ageing, which is not associated with clinical characteristics.

MOLECULAR PSYCHIATRY (2023)

Article Biology

Aβ efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas

Nirmal Verma, Gopal Viswanathan Velmurugan, Edric Winford, Han Coburn, Deepak Kotiya, Noah Leibold, Laura Radulescu, Sanda Despa, Kuey C. Chen, Linda J. Van Eldik, Peter T. Nelson, Donna M. Wilcock, Gregory A. Jicha, Ann M. Stowe, Larry B. Goldstein, David K. Powel, Jeffrey H. Walton, Manuel F. Navedo, Matthew A. Nystoriak, Andrew J. Murray, Geert Jan Biessels, Claire Troakes, Henrik Zetterberg, John Hardy, Tammaryn Lashley, Florin Despa

Summary: Impairment of vascular pathways contributes to Alzheimer's disease. Blood amylin secreted from the pancreas perturbs cerebral A beta clearance, leading to amylin and A beta co-deposits in the brain microvasculature. Altering bloodborne amylin could potentially reduce cerebrovascular amylin deposits and A beta pathology.

COMMUNICATIONS BIOLOGY (2023)

Article Neurosciences

Reliability and clinical utility of spatially constrained estimates of intrinsic functional networks from very short fMRI scans

Marlena Duda, Armin Iraji, Judith M. Ford, Kelvin O. Lim, Daniel H. Mathalon, Bryon A. Mueller, Steven G. Potkin, Adrian Preda, Theo G. M. Van Erp, Vince D. Calhoun

Summary: By using spatially constrained independent component analysis (scICA), this study found that rsfMRI scans of just 2-5 minutes can provide good clinical utility without significant loss of individual functional network connectivity (FNC) information from longer scan lengths.

HUMAN BRAIN MAPPING (2023)

Article Pharmacology & Pharmacy

Establishing Core Symptoms of Acute Serotonin Reuptake Inhibitor Withdrawal: Results from an International Survey of Online Peer-Support Communities

Bryan Shapiro, Eric Kramer, Dina Khoury, Adrian Preda

Summary: This study investigated the prevalence and severity of common withdrawal symptoms after chronic antidepressant treatment. The symptoms of dizziness, brain zaps, irritability/agitation, and anxiety/nervousness showed the largest increase in severity during withdrawal. Almost all participants reported worsening of at least one of these four symptoms. Incorporating these four core symptoms into a screening test may be useful in ruling out antidepressant withdrawal.

PHARMACOPSYCHIATRY (2023)

Article Clinical Neurology

Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in Schizophrenia

Eun-jin Cheon, Alie G. Male, Bingchen Gao, Bhim M. Adhikari, Jesse T. Edmond, Stephanie M. Hare, Aysenil Belger, Steven G. Potkin, Juan R. Bustillo, Daniel H. Mathalon, Judith M. Ford, Kelvin O. Lim, Bryon A. Mueller, Adrian Preda, Daniel O'Leary, Gregory P. Strauss, Anthony O. Ahmed, Paul M. Thompson, Neda Jahanshad, Peter Kochunov, Vince D. Calhoun, Jessica A. Turner, Theo G. M. van Erpa

Summary: This study examined the association between resting-state amplitude of low frequency fluctuations (ALFF) and negative symptoms in schizophrenia. It found positive associations between total negative symptom scores and ALFF in temporal and frontal brain regions. Additionally, it found that negative symptom domain scores had stronger associations with regional ALFF compared to total scores, suggesting that domain scores may be better indicators of neural signatures.

PSYCHIATRY RESEARCH-NEUROIMAGING (2023)

Article Neurosciences

A method for capturing dynamic spectral coupling in resting fMRI reveals domain-specific patterns in schizophrenia

Deniz Alacam, Robyn Miller, Oktay Agcaoglu, Adrian Preda, Judith Ford, Vince Calhoun

Summary: In this study, a framework was proposed to analyze time-resolved spectral coupling among different brain circuits using independent component analysis. The results showed significant differences in visual network connectivity and spectral power profiles between people with schizophrenia and healthy controls. This approach can be useful in understanding the underlying causes of impaired visual processing in schizophrenia.

FRONTIERS IN NEUROSCIENCE (2023)

Editorial Material Pharmacology & Pharmacy

Case reports in neuropharmacology 2022

Adrian Preda

FRONTIERS IN PHARMACOLOGY (2023)

Article Neurosciences

Effect of Post-COVID-19 on Brain Volume and Glucose Metabolism: Influence of Time Since Infection and Fatigue Status

Justin R. Deters, Alexandra C. Fietsam, Phillip E. Gander, Laura L. Boles L. Ponto, Thorsten Rudroff

Summary: Combining MRI and PET imaging with FDG can provide a comprehensive overview of the effects of PCS on brain volumes and metabolism. This study found differences in MRI/PET outcomes between individuals <6 months and >6 months post-COVID-19, as well as associations between these outcomes and fatigue symptoms.

BRAIN SCIENCES (2023)

Review Clinical Neurology

A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia

Atri Chatterjee, Veronica Hirsch-Reinshagen, Imogene Scott, Neil Cashman, Ging-Yuek Robin Hsiung

Summary: This study conducted a systematic review and found that the frequency of psychosis in FTD patients was 24.2%. Among the genetic mutation carriers, C9orf72 mutation carriers had the highest frequency of psychosis (31.4%), while GRN and MAPT mutation carriers had lower frequencies of psychosis. Among the pathological subtypes, patients with FUS pathology, TDP-43 pathology, and tau pathology had a prevalence of psychosis at 30%, 25.3%, and 16.4% respectively.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Review Clinical Neurology

Anti-amyloid antibody treatments for Alzheimer & apos;s disease

Robert Perneczky, Geert Dom, Andrew Chan, Peter Falkai, Claudio Bassetti

Summary: This article summarizes the latest evidence on novel antibody therapies for Alzheimer's disease targeting amyloid-β, indicating significant breakthroughs in slowing disease progression, improving clinical outcomes, and reducing amyloid-β levels.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Identifying canonical and replicable multi-scale intrinsic connectivity networks in 100k+resting-state fMRI datasets

A. Iraji, Z. Fu, A. Faghiri, M. Duda, J. Chen, S. Rachakonda, T. DeRamus, P. Kochunov, B. M. Adhikari, A. Belger, J. M. Ford, D. H. Mathalon, G. D. Pearlson, S. G. Potkin, A. Preda, J. A. Turner, T. G. M. van Erp, J. R. Bustillo, K. Yang, K. Ishizuka, A. Faria, A. Sawa, K. Hutchison, E. A. Osuch, J. Theberge, C. Abbott, B. A. Mueller, D. Zhi, C. Zhuo, S. Liu, Y. Xu, M. Salman, J. Liu, Y. Du, J. Sui, T. Adali, V. D. Calhoun

Summary: This study identifies replicable multi-spatial-scale canonical intrinsic connectivity network (ICN) templates using rsfMRI data from over 100k individuals through multi-model-order independent component analysis (ICA). The feasibility of estimating subject-specific ICNs via spatially constrained ICA is also studied. The results show that subject-level ICN estimations vary as a function of the ICN itself, the data length, and the spatial resolution. Longer scans may not always be desirable and spatial smoothness should be considered in optimizing data length.

HUMAN BRAIN MAPPING (2023)

Article Clinical Neurology

Auditory oddball hypoactivation in schizophrenia

Soichiro Nakahara, Alie G. Male, Jessica A. Turner, Vince D. Calhoun, Kelvin O. Lim, Bryon A. Mueller, Juan R. Bustillo, Daniel S. O'Leary, James Voyvodic, Aysenil Belger, Adrian Preda, Daniel H. Mathalon, Judith M. Ford, Guia Guffanti, Fabio Macciardi, Steven G. Potkin, Theo G. M. Van Erp

Summary: Individuals with schizophrenia show abnormal brain activation during auditory oddball tasks, which is associated with cognitive performance and genetic contributions. This study compares individuals with schizophrenia to healthy volunteers and identifies novel relationships between regional brain activity, cognitive performance, and genetic loci. The findings highlight the importance of continued data sharing and collaborative efforts in schizophrenia research.

PSYCHIATRY RESEARCH-NEUROIMAGING (2023)

No Data Available